Skip to content Skip to footer
NovoSeven RT: Benefits, Reviews, Info, Side Effects!
Rx Details
NovoSeven RT
NovoSeven, Recombinant Factor VIIa, Eptacog alfa
Coagulation factor VIIa
Prescription
Medication
Drugs
Prescription Only
Treatment of bleeding episodes in hemophilia A or B patients with inhibitors, management of bleeding in patients with acquired hemophilia, treatment of bleeding in patients with congenital factor VII deficiency, control of bleeding in patients with Glanzmann’s thrombasthenia with refractoriness to platelet transfusions.
Allergic Reactions, Blood Clots, Fever, Headache, Injection Site Reactions, Joint Pain, Nausea, Rash, Vomiting
NovoSeven RT (coagulation factor VIIa, recombinant) is a medication used to treat bleeding episodes in individuals with hemophilia or other bleeding disorders. The dosage of NovoSeven RT can vary significantly based on the specific condition being treated, the severity of the bleeding, and the patient’s individual response to the medication. For hemophilia A or B with inhibitors, the typical dosage is often in the range of 90 micrograms per kilogram of body weight, administered every two to three hours until hemostasis is achieved. However, dosages can vary, and some protocols may use different dosing strategies. It’s crucial to follow the specific dosing instructions provided by a healthcare professional, as they will tailor the dosage to the patient’s needs. Always consult with a healthcare provider or refer to the prescribing information for the most accurate and personalized dosing guidance.
Bleeding disorders, hemophilia a, hemophilia b, factor vii deficiency, glanzmann’s thrombasthenia
NovoSeven RT has a favorable safety profile.
No Interactions Reported
$1,500 – $3,000
$1,500 – $2,000 per vial

A Synopsis of

NovoSeven RT

NovoSeven RT is a medication that is commonly used in the treatment of bleeding episodes in patients with certain bleeding disorders, such as hemophilia A or B. This medication works by helping the blood to clot more effectively, which can be crucial in preventing excessive bleeding and promoting healing.

NovoSeven RT is a recombinant form of activated factor VII, a protein that plays a key role in the blood clotting process. By administering this medication, healthcare providers can help to restore the balance of clotting factors in the blood, reducing the risk of uncontrolled bleeding.

It is important to note that NovoSeven RT should only be used under the supervision of a healthcare professional, as it is a potent medication that can have serious side effects if not used correctly. Patients should be closely monitored while taking this medication to ensure that it is working effectively and that any potential side effects are managed appropriately.

While NovoSeven RT can be a lifesaving medication for patients with certain bleeding disorders, it is not without risks. Patients should be aware of the potential side effects of this medication, which can include blood clots, allergic reactions, and other serious complications. It is important to discuss any concerns or questions about NovoSeven RT with your healthcare provider before starting treatment.

Overall, NovoSeven RT is a valuable medication for patients with certain bleeding disorders, but it should be used with caution and under the guidance of a healthcare professional. By working closely with your healthcare team, you can ensure that you are receiving the appropriate treatment for your condition and that any potential risks are minimized.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN